Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies.
(Q46030933)
scientific article published in May 2009
scientific article published in May 2009
Language: